SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors react to a strong earnings report and the companys decision to maintain capital expenditure levels, which has effectively eased market anxiety regarding AI infrastructure spending. The community is actively debating the company's ability to drive long-term cloud and AI growth while highlighting its status as a stabilizing force amid broader market volatility.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the UAE's broad regulatory approval of Anktiva, which marks a significant milestone in the company's global expansion and validates its therapeutic potential. While the community is actively debating the significance of international market entry versus the need for more substantial domestic clinical updates, many investors remain focused on upcoming quarterly earnings as a key indicator of commercial growth and a potential catalyst for price action.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta shares are facing downward pressure as investors react to a significant earnings miss and raised capital expenditure guidance for AI infrastructure, which has severely compressed free cash flow. While some in the community argue this represents a durable, long-term buying opportunity in an advertising cash cow, others are actively debating whether these heavy investments can yield sufficient returns or if they will continue to weigh on shareholder value.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as a sharp spike in Treasury yields and ongoing geopolitical instability in the Middle East fuel investor concerns over long-term inflation and the viability of long-duration bonds. The community is actively debating whether this represents a critical flight-to-safety opportunity or a signal of deeper systemic economic weakness ahead of upcoming economic data.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is facing intense investor scrutiny ahead of earnings as concerns over ballooning AI infrastructure spending weigh on the stock. Market sentiment remains volatile as shareholders weigh the company's long-term cloud potential against short-term risks of elevated capital expenditures and regulatory pressure.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant investor interest driven by a series of record-breaking ABS issuances and strong analyst support that suggests the company is significantly undervalued relative to its fintech peers. The community remains focused on whether management's bullish execution and insider share purchases by the CEO will be enough to overcome broader macro volatility and lingering concerns about credit performance.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Russell 2000 is currently grappling with heightened volatility as market participants weigh aggressive institutional put buying against resilience in small-cap sectors. Traders are heavily focused on the interplay between climbing bond yields, geopolitical instability, and anticipation of the upcoming Fed rate decision, which is forcing a shift in sentiment regarding whether small caps can maintain their current support levels.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is gaining significant community attention as shareholders speculate on a potential buyout following recent analyst price target hikes and ongoing momentum from Briumvi's commercial success. Investors are closely monitoring strong revenue growth and upcoming clinical trial developments while actively debating the stock's valuation relative to its expansion into new autoimmune indications.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group Inc. is experiencing high volatility as shareholders react to the FDA accepting a resubmission for its melanoma treatment, with many community members debating whether this third attempt will yield a favorable outcome or another Complete Response Letter. Investors are closely monitoring upcoming advisory committee meetings and the potential for significant dilution, while the community remains polarized between those anticipating an approval-driven squeeze and others warning of a permanent decline.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is experiencing significant market attention following a better-than-expected Q2 earnings report, with community discussion centered on successful growth initiatives like menu innovation and AI-driven efficiency. While some investors are highlighting the raised full-year outlook and strong demand as a bullish signal, others remain focused on broader sector concerns regarding consumer spending resilience and supply chain management.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bausch Health (BHC) Q2 Earnings and Revenues Beat Estimates

Bausch (BHC) delivered earnings and revenue surprises of +31.25% and +7.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates

SolGel Technologies (SLGL) delivered earnings and revenue surprises of +28.80% and -88.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Up 48.9% in April

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totaling 18,688 shares, an increase of 48.9% from the March 31st total of 12,551 shares. Based on an average trading volume of...

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Down 31.7% in March

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) was the target of a large decline in short interest in the month of March. As of March 31st, there was short interest totaling 12,551 shares, a decline of 31.7% from the March 15th total of 18,373 shares. Based on an average daily volume of...

Sol-Gel Technologies (NASDAQ:SLGL)  Shares Down 0.6%   - Time to Sell?

Sol-Gel Technologies (NASDAQ:SLGL) Trading Down 0.6% - Here's Why...

Sol-Gel Technologies (NASDAQ:SLGL) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen raised shares of Sol-Gel Technologies from a "hold" rating to a "buy" rating in a research note on Saturday...

Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates

SolGel Technologies (SLGL) delivered earnings and revenue surprises of -374.36% and -89.29%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Update

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 27th, there was short interest totaling...

Sol-Gel Technologies (SLGL) to Release Earnings on Wednesday

Sol-Gel Technologies (NASDAQ:SLGL) will be releasing earnings before the market opens on Wednesday, March 11. (View Earnings Report at...

Short Interest in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Decreases By 23.4%

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) saw a large drop in short interest in the month of February. As of February 13th, there was short interest totaling 5,775 shares, a drop of...

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Sol-Gel Technologies Ltd

Sol-Gel Stock Tumbles Over Underwhelming Q1 Earnings: Retail Stays Pessimistic

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$82.55
Prev Close	$83.07
Open	$84.23
Dividend Yield	0.00%
50-Day Moving Average	$75.28
Beta	0.62
Avg. Volume	33,440.65
PE Ratio	-234.97

52-Week High	$97.97
52-Week Low	$10.95
Market Capitalization	$271.56M
EPS (Annual)	-$2.20
Price to Book	5.25
Revenue Per Employee	$692,428.57

Feed

News

Sentiment

Earnings

Fundamentals

Info

SLGLSol-Gel Technologies Ltd

Latest SLGL News